%20(1).svg)
Presentation: Strategies for Amorphous Solid Dispersion Product Development
Presentation: Strategies for Amorphous Solid Dispersion Product Development
Erica Schlesinger, Ph.D
VP of Technical Development
Abstract:
In this talk, presented during the 2024 Global Drug Bioavailability Enhancement & Controlled & Modified Drug Release Summit, we present a multifaceted approach to technology selection for enabled formulations. We demonstrate how to leverage a combination of measured and calculated molecular properties, bio-performance modeling, and a strategic understanding of the product TPP to identify a technology to enable exposure and an appropriate drug product design. Watch the presentation to learn more.
KEY LEARNINGS:
Strategic drug product design supports a flexible TPP that allows for development of a relevant and advanceable dosage form for FIH studies
Considering TPP/Product Design in ASD screening
Considering impact of particle properties (SDD vs HME) in product design & performance
About Serán
Serán BioScience, LLC, is a science-driven Drug Development Partner, recognized as a world leader in drug development. Utilizing a foundation of physical and chemical science, Serán designs robust formulations and engineered solutions to some of the industry's toughest drug product problems. Our experience and background cover a wide range of pharmaceutical manufacturing concepts bringing our world-class expertise to you and your drug product. Serán’s team has decades of experience developing complex drug molecules into enabling medicines. With every addition to our team, we further our commitment to our clients’ success. From preclinical to GMP and beyond, Serán is here to support you and your drug product every step of the way.
For more information, visit www.Seranbio.com or email us at hello@seranbio.com.
Contact
Serán BioScience, LLC
63047 Layton Ave, Bend, OR 97701 USA
www.seranbio.com
.svg)